John Nuss, Chief Scientific Officer at Ventyx Biosciences, Inc. (VTYX), sold 20,000 shares at $33.41 ($652K) on 2023-09-05, disclosed to the SEC on 2023-09-07.
Open-market sale of $652k VTYX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.24 | 6,991 | $225K | 34.6% |
| 2 | $32.24 | 6,991 | $225K | 34.6% |
| 3 | $33.41 | 3,009 | $101K | 15.4% |
| 4 | $33.41 | 3,009 | $101K | 15.4% |
| Total | $32.59 avg | 20,000 | $652K | 100% |
| Filing → |
| VTYX | SELL | 2024-12-30 | $50K | — | Filing → |
| VTYX | SELL | 2024-12-19 | $30K | — | Filing → |
| VTYX | SELL | 2024-04-03 | $9K | — | Filing → |